Clinical Trial Update: Central China Rosai-Dorfman Disease Registry [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for Rosai-Dorfman Disease registry in Central China; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Langerhans Cell Histiocytosis
• Rosai-dorfman Disease

Snippet

Sponsor: Tongji Hospital | Conditions: Rosai-Dorfman Disease, Langerhans Cell Histiocytosis | Phase 4 | Status: UNKNOWN